We are creating a new paradigm based on the value of real-time PCR and syndromic testing. Our technology makes it possible to detect hundreds of pathogens on a single platform.
Real-time PCR combines amplification and detection into a single step. The short turnaround time (TAT) and Seegene’s high multiplex assays enable the identification and detection of multiple pathogens in a single test.
To support fast and accurate detection, we provide automated systems that can be used for various types of products.
Learn more about all the assays we offer—search by disease type below.
The Allplex™ 2019-nCoV (SARS-CoV-2) Assay is available in the US under Emergency Use Authorization (EUA). Seegene is playing a critical role in offering effective testing solutions that include current variants to mitigate the spread of rapidly mutating COVID-19 viruses.
The Seegene Novaplex™ assays are Research Use Only (RUO), real-time reverse transcriptase polymerase chain reaction (RT-PCR) tests that maximize test efficiency and offer excellent performance. These syndromic assays simultaneously test for multiple targets in short running time with reduced reagents cost and minimal labor required.
*Novaplex™ Assays are For Research Use Only. Not for Use in Diagnostic Procedures.
**Allplex™ 2019-nCoV Assay is for Emergency Use Authorization.